Serum CA 19-9, SLX, STN and CEA levels of the peripheral and the draining venous blood in gastric cancer

Hepato-Gastroenterology

Volumn 46, Issue 27, 1999, Pages 2086-2090

  Imada, Toshio ^a   Rino, Yasushi ^a   Takahashi, Makoto ^a   Hatori, Shinsuke ^a   Shiozawa, Manabu ^a   Amano, Tomishige ^a   Kondo, Jiro ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Carbohydrate antigen; Gastric cancer

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PATHOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STOMACH CANCER; VENOUS BLOOD;

ADULT; AGED; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; FEMALE; GASTRECTOMY; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; OLIGOSACCHARIDES; PROGNOSIS; SENSITIVITY AND SPECIFICITY; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0032764657     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Imada T, Rino Y, Takahashi M, et al: Expression of CA19-9,SLX,STN and CEA in relatively early gastric carcinoma. Oncology Rep 1997; 4:899-904.
2. Japanese Research Society for Gastric Cancer: The General Rules for Gastric Cancer Study. 12th Ed. Kanehara Press, Tokyo 1993.
3. Nakazaki H, Mitomi T, Noto T, et al: Mosaicism in the expression of tumor-associated carbohydrate antigens in human colonic and gastric cancers. Cancer Res 1989; 49:3662-3669.
4. Fukushi Y, Kannagi R, Hakomori S, et al: Location and distribution of difucoganglioside in normal and tumor tissues defined by its monoclonal antibody FH6. Cancer Res 1985; 45:3711-3717.
5. Joypaul B, Browning M, Newman E, et al: Comparison of serum CA 72-4 and CA 19-9 levels in gastric cancer patients and correlation with recurrence. Am J Surg 1995; 169:595-599.
6. Motoo Y, Kawakami H, Watanabe H, et al: Serum Sialyle-Tn antigen levels in patients with digestive cancers. Oncology 1991; 48:321-326.
7. Ritts RE, Del Villano BC, Go VL, et al: Initial clinical evaluation of an immunoradiometric assay for CA19-9 using the NCI serum bank. Int. J Cancer 1984; 33:339-345.
8. Guadagni F, Roselli M, Amato T, et al: CA 72-4 measurement of tumor associated glycoprotein 72(TAG-72) as a serum marker in the management of gastric carcinoma. Cancer Res 1992; 52:1222-1227.
9. Takahashi I, Maehara Y, Kusumoto T, et al: Predictive value of preoperative serum Sialyl Tn antigen levels in prognosis of patients with gastric cancer. Cancer 1993; 72:1836-1840.
10. Yamada T, Watanabe A, Yamada Y, et al: Sialosyl Tn antigen expression is associated with the prognosis of patients with advanced gastric cancer. Cancer 1995; 76:1529-1536.
11. Tabuchi Y, Deguchi H, Saitoh Y: Carcinoembryonic antigen levels of portal blood in gastric cancer patients. J Surg Res 1989; 47:81-86.
12. Hirose T, Namatame K: Drainage of CEA and CA19-9 to the peripheral blood in gastric cancer patients. Nippon Shokakigeka Gakkaizasshi 1994; 27:2079-2086.
13. Kakeji K, Maehara Y, Morita M, et al: Correlation between sialyl Tn antigen and lymphatic metastasis in patients with Borrmann type IV gastric carcinoma. Br J Cancer 1995; 71:191-195.